To determine the seroprevalence of antibodies against dengue virus (DENV) and West Nile virus (WNV) in the human population of the Bolivian Chaco, we tested 256 inhabitants of two rural communities. The seroprevalence, confirmed by plaque reduction neutralization test, was 7.8% and 2.7% for DENV and WNV, respectively.
Seroprevalence of West Nile and dengue virus in the human population of the Bolivian Chaco / Bartoloni, A.; Remoli, M. E.; Farchi, F.; Zammarchi, L.; Fortuna, C.; Benedetti, E.; Ciufolini, M. G.; Macchioni, F.; Rojas, P.; Lara, Y.; Padilla, C.; Roselli, M.; Mantengoli, E.; Mantella, A.; Tolari, F.; Paredes, G. A.; Monasterio, J.; Valdarchi, C.; Venturi, G.; Rezza, G.. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 0146-6615. - 91:1(2019), pp. 146-150. [10.1002/jmv.25283]
Seroprevalence of West Nile and dengue virus in the human population of the Bolivian Chaco
Rezza G.Ultimo
2019-01-01
Abstract
To determine the seroprevalence of antibodies against dengue virus (DENV) and West Nile virus (WNV) in the human population of the Bolivian Chaco, we tested 256 inhabitants of two rural communities. The seroprevalence, confirmed by plaque reduction neutralization test, was 7.8% and 2.7% for DENV and WNV, respectively.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
